Search results
Results from the WOW.Com Content Network
On 21 April 2021, NHC stated that more than 200 million doses of COVID-19 vaccine has been administered in China, and 80% of doctors and nurses has been vaccinated. [ 13 ] On 14 May 2021, NHC restated that the COVID-19 administration progress should be accelerated due to the proportion of mutated SARS-CoV-2 and the re-appearance of local cases.
The plan, which is set from 2011 to 2020, is intended to "strengthen routine immunization to meet vaccination coverage targets; accelerate control of vaccine-preventable diseases with polio eradication as the first milestone; introduce new and improved vaccines and spur research and development for the next generation of vaccines and technologies."
As of February 2021 China had provided vaccines to 53 developing countries and vaccine exports to 22 countries. [ 152 ] [ 154 ] Foreign Minister Wang Yi criticized developed countries for hoarding vaccines and urged the international community to "promote fair and equitable distribution of vaccines".
The FTC (and DOJ) should return to the consumer welfare standard instead of persisting in the economic illiteracy and noncomprehensive jurisprudence promulgated by the 2023 guidelines.
In China, which has relied on locally produced COVID-19 vaccines rather than allowing mRNA products from foreign manufacturers to be imported, mRNA vaccines are still not widely used.
On 24 June 2020, China approved the CanSino vaccine for limited use in the military and two inactivated virus vaccines for emergency use in high-risk occupations. [13] On 11 August 2020, Russia announced the approval of its Sputnik V vaccine for emergency use, though one month later only small amounts of the vaccine had been distributed for use ...
The order will require all independent federal agencies and executive branches to now submit draft regulations so they can be reviewed by the White House. Trump signs executive order to expand his ...
[4] The China CDC rejected a mitigation strategy, and instead explained that "[t]he current strategic goal is to maintain no or minimal indigenous transmission of SARS-CoV-2 until the population is protected through immunisation with safe and effective COVID-19 vaccines, at which time the risk of COVID-19 from any source should be at a minimum ...